Dr. Reddy’s to focus on complex products as growth drivers to offset Revlimid revenue loss
Dr. Reddy’s is focusing on a pipeline of complex drugs, including GLP-1 (such as Semaglutide) as well as biosimilars and consumer care to offset the loss of exclusivity for its blockbuster drug ...